BRIDGEWATER, NJ--(Marketwire - June 19, 2008) - Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, announced today changes to its Executive Leadership Team. Ron Warner has been appointed to the position of Executive Vice President and Chief Scientific Officer. In this new role, Ron will advise and guide multiple late-stage development projects, interface with regulatory agencies in the US and abroad, ensure technology platforms provide distinct and sustainable competitive advantages and make resource allocation decisions based upon increasingly complex choices. Additionally, Ron will support the newly created Science and Technology Committee of the Alpharma Board of Directors. Ron, who has been with Alpharma since 2002 and has served as the Pharmaceuticals Division President since 2005, will continue to serve on the Company’s Executive Leadership Team.
